3rd. Circ. Reverses GSK Win In Avandia Marketing Suit
By Mike LaSusa ( December 17, 2019, 10:32 PM EST) -- The Third Circuit ruled in a precedential opinion Tuesday that a Pennsylvania federal judge erred on several grounds in granting summary judgment to GlaxoSmithKline in a lawsuit over the marketing of the diabetes drug Avandia....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.